Analysis & Validation Service

We begin by reviewing the client's probe, biological model, assay goal, and downstream application.

• Define the target mitochondrial readout, such as ΔΨm, ROS, ATP/ADP, NADH/NAD⁺, Ca²⁺, pH, mitophagy, morphology, apoptosis, or multi-parameter function.
• Review the probe type, reporter system, stable cell line, disease model, treatment condition, or screening plan.
• Clarify the preferred detection platform, such as fluorescence microscopy, confocal imaging, flow cytometry, plate-reader assay, high-content imaging, or metabolic profiling system.
• Determine whether the project requires probe characterization, HCS assay development, mitochondrial functional profiling, or an integrated validation workflow.
• Identify technical risks, such as weak signal, photobleaching, autofluorescence, nonspecific staining, poor localization, cytotoxicity, poor reproducibility, or limited assay window.

A robust analysis workflow depends on appropriate controls and validation logic.

• Design positive and negative controls.
• Select mitochondrial uncouplers, respiratory inhibitors, ROS inducers, antioxidants, ionophores, apoptosis inducers, lysosomal modulators, or mitophagy regulators.
• Define vehicle controls, untreated controls, rescue controls, and pathway-specific perturbation conditions.
• Plan orthogonal readouts to confirm probe interpretation.
• Establish assay acceptance criteria, including signal window, dynamic range, reproducibility, and biological relevance.

We optimize the probe or assay conditions before full validation or screening.

• Optimize probe concentration, loading time, washing conditions, incubation time, and imaging window.
• Evaluate cell seeding density, treatment duration, plate format, and sample handling conditions.
• Test signal-to-background ratio, staining uniformity, photostability, and signal persistence.
• Assess cell permeability, mitochondrial localization, nonspecific organelle accumulation, and cytotoxicity.
• Refine imaging or detection settings, including exposure time, laser intensity, filters, channels, and acquisition timing.

Once assay conditions are defined, we acquire probe-based or functional assay data under controlled conditions.

• Perform fluorescence microscopy or confocal imaging.
• Perform flow cytometry or plate-reader acquisition when required.
• Acquire high-content imaging data.
• Collect multi-channel images with mitochondrial, nuclear, lysosomal, apoptosis, or viability markers.
• Acquire bioenergetic or luminescent assay data when required.
• Conduct plate-level quality control, including focus quality, cell number, edge effects, saturation, debris, autofluorescence, compound precipitation, and signal consistency.

We convert probe signals and images into interpretable quantitative readouts.

• Analyze fluorescence intensity.
• Calculate ratiometric signals.
• Analyze red/green ratios.
• Calculate ΔF/F₀.
• Compare mitochondrial and cytosolic signals.
• Perform co-localization analysis.
• Count puncta and analyze organelle overlap.
• Extract mitochondrial morphology features, including length, branching, circularity, fragmentation, and network connectivity.
• Generate dose-response, time-course, heatmap, clustering, or phenotype scoring analysis.

After analysis, we interpret the results in the context of mitochondrial biology and the client's project goal.

• Distinguish primary mitochondrial effects from nonspecific cytotoxicity or secondary stress.
• Compare treatment groups, disease models, control conditions, and rescue conditions.
• Rank probe candidates, compounds, or assay conditions.
• Identify potential false positives caused by autofluorescence, precipitation, cell loss, or nonspecific staining.
• Recommend secondary validation assays.
• Prepare a final report with methods, representative images, quantitative results, assay limitations, and follow-up recommendations.

Probe Candidate Qualification

This service helps evaluate whether a new mitochondrial probe candidate is suitable for biological use. Optical behavior, target response, selectivity, mitochondrial localization, cytotoxicity, and assay compatibility can be assessed before moving into full biological validation or screening.

Mitochondrial Assay Development

Probe-based assays often require optimization before they can generate reliable data. Analysis and validation services support assay development for membrane potential, ROS, redox status, ion signaling, pH, energy metabolism, mitophagy, fusion/fission, mitochondrial turnover, apoptosis, and viability.

Drug Screening and Toxicity Evaluation

Analysis and validation workflows can support compound screening, mitochondrial toxicity evaluation, cardiotoxicity assessment, hepatotoxicity models, cancer drug response studies, and mitochondrial rescue assays. Probe-based HCS and functional profiling can help identify mitochondrial liability or therapeutic activity.

Disease Model and Mechanism Research

Disease models often show complex mitochondrial phenotypes. Multi-parameter validation can help compare disease versus control cells, treated versus untreated models, resistant versus sensitive phenotypes, or rescue versus injury conditions.